Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Pasithea Therapeutics Corp.US flagNASDAQ Capital Market
0.51
USD
-0.01
- -
3.81MMarket Cap

Pasithea Therapeutics Corp. (KTTA) Stock Split History

Learn about Pasithea Therapeutics Corp.'s most recent 1-for-20 basis stock split on January 02, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Pasithea Therapeutics Corp.'s most recent stock split

Split Date: 2024-01-02
Split Ratio: 1:20
Price Before Split: $0.40
Price After Split: $0.02

Developer API

Get KTTA split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/KTTA

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Pasithea Therapeutics Corp.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-01-021:20Yes$0.40$0.02

About Pasithea Therapeutics Corp.

Company overview and industry information

Pasithea Therapeutics Corp. (KTTA) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Pasithea Therapeutics Corp. Summary

Last updated: 7/8/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.